Advertisements


We are Sorry, This Page doesn't Exist


KeyBanc upgrades Pioneer Natural on potential guidance upside

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 13th, 2021

Column: Paper boosting stem cell firm"s treatments is retracted

A paper co-authored by an executive of a stem cell firm already under FDA fire has been retracted.A paper co-authored by an executive of a stem cell firm already under FDA fire has been retracted......»»

Category: topSource: latimesMay 4th, 2021

Column: Paper boosting stem cell firm"s treatments is retracted

A paper co-authored by an executive of a stem cell firm already under FDA fire has been retracted. A paper co-authored by an executive of a stem cell firm already under FDA fire has been retracted......»»

Category: topSource: latimesMay 4th, 2021

Boosted by celebrity endorsements and a controversial research program, clinics are peddling stem cell autism treatments questioned by experts

A research program into stem cells and autism is attracting criticism. Experts say it is unwittingly boosting a market .....»»

Category: topSource: businessinsiderJan 13th, 2021

CareDx"s AlloSeq HCT wins tender for stem cell transplant surveillance

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 4th, 2021

Column: Don"t be taken in by stem cell firms offering unsubstantiated therapies for COVID-19

Clinics with unproven stem cell treatments are already targeting COVID-19 fears. Clinics with unproven stem cell treatments are already targeting COVID-19 fears......»»

Category: topSource: latimesMay 14th, 2020

Citius reports pre-IND submission for stem cell therapy for ARDS in COVID-19

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 27th, 2020

Cellect Biotechnology Reports Fourth Quarter and Full Year 2019 Results

TEL AVIV, Israel, April 3, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ:APOP), a developer of a novel stem cell production technology, today announced operating and financial results for th.....»»

Category: earningsSource: benzingaApr 3rd, 2020

Fluidigm says CyTOF technology used to evaluate stem cell therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 2nd, 2020

"This can happen to anyone": How this cell therapy pioneer, diagnosed with the coronavirus, wants to destigmatize COVID-19

Dr. Arie Belldegrun, a pioneer in the burgeoning area of cell therapy, has the coronavirus and a simple message: Get tested. Belldegrun, the cofounder and executive chairman of cell therapy company Allogene Therapeutics Inc. (NASDAQ: ALLO) of Sout.....»»

Category: topSource: bizjournalsMar 16th, 2020

Column: U.S. judge rejects FDA bid to shut down stem cell clinics, dealing blow to regulators

A U.S. judge throws a wrench into the FDA's campaign against stem cell clinics. A U.S. judge throws a wrench into the FDA's campaign against stem cell clinics......»»

Category: topSource: latimesJan 28th, 2020

Cellect Biotech Shares Rip On Intention To Award Stem Cell-related Patents In Europe, Israel

Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) shares are more than doubling following an announcement concerning patents in two regions. 0 read more.....»»

Category: blogSource: benzingaJan 7th, 2020

Column: The California stem cell program"s $5.5-billion funding request might be its downfall

The California.....»»

Category: topSource: latimesDec 8th, 2019

Local biotech, academics eyeing $5.5 billion stem cell measure

As California’s stem cell research agency prepares to seek another $5.5 billion from taxpayers, local biotech researchers and companies are keeping a close eye on where those dollars go.  The California Institute for Regenerative Medicine was fo.....»»

Category: topSource: bizjournalsNov 11th, 2019

DogVacay founder wants to bank your dog"s stem cells

Former DogVacay Aaron Hirschhorn on how his beloved dog Rocky has inspired not one, but two startups, including his latest, Gallant — a stem cell banking solution for dogs......»»

Category: topSource: bizjournalsOct 24th, 2019

California"s stem cell agency, out of cash, seeks $5.5B in taxpayer backing for new lease on life

The architect of the 2004 ballot measure that created California's stem cell research funding initiative wants to put a $5.5 billion initiative on the November 2020 ballot......»»

Category: topSource: bizjournalsOct 21st, 2019

California"s stem cell agency, out of cash, seeks $5.5 billion for new lease on life

The architect of the 2004 ballot measure that created California's stem cell research funding initiative wants to put a $5.5 billion initiative on the November 2020 ballot......»»

Category: topSource: bizjournalsOct 21st, 2019

The "Dr. Death" podcast team has a new medical investigation that delves into greed and desperation in the stem cell industry

Wondery The t.....»»

Category: topSource: businessinsiderOct 18th, 2019

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2019 Financial Results

OLDSMAR, Fla., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB) (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, announced resu.....»»

Category: earningsSource: benzingaOct 15th, 2019

Citi sees potential upside of 65% in Pioneer Natural shares

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 8th, 2019